InfuSystems Holdings, Inc. (INFU) earnings
INFU earnings moved a median of +0.10% by the close. Quarterly and annual INFU reports and results, each read against the price at its own news timestamp. Back to the INFU overview →
32 measured INFU earnings events.
Where these INFU earnings landedvs 32 measured INFU earnings reactions
| Middle 50% of INFU earnings reactions | -2.12% to +4.75% |
|---|---|
| Median reaction (to close) | +0.10% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 INFU earnings events with a measured close landed between -2.12% and +4.75%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q InfuSystem Holdings, For: Jun 30 | SEC filing · Form 10-Q | -0.70% | +0.03% | |
| InfuSystem Announces Financial Results for Second Quarter 2026 | Press release | +1.58% | +21.50% | |
| InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026 | Press release | -0.32% | +5.20% | |
| Form 10-Q InfuSystem Holdings, For: Mar 31 | SEC filing · Form 10-Q | — | -2.77% | |
| InfuSystem Announces Financial Results for First Quarter 2026 | Press release | +4.92% | +7.55% | |
| InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | -1.07% | +2.01% | |
| Form 10-K InfuSystem Holdings, For: Dec 31 | SEC filing · Form 10-K | +13.76% | +27.43% | |
| Form 10-Q InfuSystem Holdings, For: Sep 30 | SEC filing · Form 10-Q | -0.05% | +4.71% | |
| InfuSystem Reports Third Quarter 2025 Financial Results | Press release | -5.73% | +2.27% | |
| InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025 | Press release | -0.91% | +0.57% | |
| Form 10-Q InfuSystem Holdings, For: Jun 30 | SEC filing · Form 10-Q | +1.13% | +15.64% | |
| InfuSystem Reports Second Quarter 2025 Financial Results | Press release | -2.96% | -0.33% | |
| InfuSystem to Report Second Quarter 2025 Financial Results on August 5, 2025 | Press release | +0.00% | -3.06% | |
| Form 10-Q InfuSystem Holdings, For: Mar 31 | SEC filing · Form 10-Q | +0.36% | -1.08% | |
| InfuSystem Reports First Quarter 2025 Financial Results | Press release | -0.39% | +6.21% | |
| InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | -1.05% | -0.21% | |
| Form 10-K InfuSystem Holdings, For: Dec 31 | SEC filing · Form 10-K | +0.53% | +1.25% | |
| Form 10-Q InfuSystem Holdings, For: Sep 30 | SEC filing · Form 10-Q | +9.99% | +14.54% | |
| InfuSystem Reports Third Quarter 2024 Financial Results | Press release | -1.43% | +4.86% | |
| InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024 | Press release | -0.81% | +0.16% | |
| Form 10-Q InfuSystem Holdings, For: Jun 30 | SEC filing · Form 10-Q | -0.58% | -0.66% | |
| InfuSystem Reports Second Quarter 2024 Financial Results | Press release | -3.98% | -5.36% | |
| InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024 | Press release | +0.66% | -2.66% | |
| Form 10-Q InfuSystem Holdings, For: Mar 31 | SEC filing · Form 10-Q | +0.93% | -3.32% | |
| InfuSystem Reports First Quarter 2024 Financial Results | Press release | +0.77% | -3.45% | |
| InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024 | Press release | -1.19% | -0.53% | |
| Form 10-K InfuSystem Holdings, For: Dec 31 | SEC filing · Form 10-K | +1.39% | +1.64% | |
| InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K | Press release | +0.86% | +0.74% | |
| Form NT 10-K InfuSystem Holdings, For: Dec 31 | SEC filing · Form NT | -1.03% | -7.30% | |
| Form 10-Q InfuSystem Holdings, For: Sep 30 | SEC filing · Form 10-Q | -0.35% | -0.46% | |
| InfuSystem Reports Third Quarter 2023 Financial Results | Press release | +0.00% | -3.79% | |
| InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023 | Press release | +0.00% | -1.95% |
Keep exploring
More INFU: analyst actions → · SEC filings → · INFU overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | 203 | 0.00% | 48% |
| Immuron Limited - American Depositary Shares (IMRN) | 202 | -0.21% | 29% |
| Regulus Therapeutics Inc. (RGLS) | 201 | +0.26% | 55% |
| Daxor Corporation - Closed End Fund (DXR) | 200 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.